Search

Author/Creator Rodgers, T.

1. FRI0370 Efficacy and safety of lesinurad (RDEA594), a novel URAT1 inhibitor, in combination with allopurinol in allopurinol-refractory gout patients: Results from a randomized, blinded, placebo-controlled, phase 2b extension study. (23rd January 2014)

Authors:
Perez-Ruiz, F.; Sundy, J.; Krishnan, E.; Hingorani, V.; Welp, J.; Rodgers, T.; Manhard, K.; Cravets, M.; Hagerty, D.; Quart, B.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
439
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Modeling of additive manufacturing processes for metals: Challenges and opportunities. Issue 4 (August 2017)

Authors:
Francois, M.M.; Sun, A.; King, W.E.; Henson, N.J.; Tourret, D.; Bronkhorst, C.A.; Carlson, N.N.; Newman, C.K.; Haut, T.; Bakosi, J.; Gibbs, J.W.; Livescu, V.; Vander Wiel, S.A.; Clarke, A.J.; Schraad, M.W.; Blacker, T.; Lim, H.; Rodgers, T.; Owen, S.; Abdeljawad, F.
Journal:
Current opinion in solid state & materials science
Issue:
Volume 21:Issue 4(2017)
Page Start:
198
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗